Compass Financial Group (South Dakota)’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$132K Hold
14,043
0.02% 103
2025
Q4
$174K Hold
14,043
0.02% 102
2025
Q3
$201K Hold
14,043
0.03% 101
2025
Q2
$172K Buy
+14,043
New +$204K 0.03% 96

Other funds holding IART

Compass Financial Group (South Dakota)'s IART Position: Q1 2026 in Review

Compass Financial Group (South Dakota) held its Integra LifeSciences (IART) position steady in Q1 2026 at 14,043 shares worth $132K. The position accounts for 0.02% of the portfolio, ranked #103.

Compass Financial Group (South Dakota) first reported a position in IART in Q2 2025 and has held it in 4 quarters since. The position peaked at $201K in Q3 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Compass Financial Group (South Dakota) held 14,043 shares of Integra LifeSciences worth $132K as of Q1 2026.
  • Compass Financial Group (South Dakota) left its Integra LifeSciences share count unchanged in Q1 2026.
  • Integra LifeSciences made up 0.02% of Compass Financial Group (South Dakota)'s portfolio in Q1 2026, its #103 holding.
  • Compass Financial Group (South Dakota) first reported a position in Integra LifeSciences in Q2 2025 and has held it in 4 quarters since.
  • Compass Financial Group (South Dakota)'s Integra LifeSciences position peaked at $201K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Compass Financial Group (South Dakota)'s 13F filing for Q1 2026, filed 29 Apr 2026.